Additional file 2: Figure S2. The expression level of CTD-2547G23.4 in HCC. (A) Forest plot of all eligible datasets evaluating CTD-2547G23.4 expression between HCC and adjacent non-tumour tissues. (B) The SROC curve for the differentiation of HCC from adjacent non-tumour tissues based upon TCGA, GSE27462, GSE49713 and qRT-PCR datasets. (C) Forest plot of TCGA and in-house PCR datasets evaluating CTD-2547G23.4 expression between HCC and adjacent non-tumour tissues. (D) The SROC curve for the differentiation of HCC from adjacent non-tumour tissues based upon TCGA, GSE27462 and qRT-PCR datasets
Figure S1. The association between PPM1F expression and the genetic and methylation alterations in H...
Hepatocellular carcinoma (HCC) accounts for 90% of primary hepatic malignancies and is one of the ma...
Table S2. HCC-associated genes. Contains a set of genes often associated with HCC, including those r...
Additional file 8: Fig. S4. mRNA-GS is associated with less aggressive state in HCC. Dot-plots showi...
Additional file 1: Figure S1. Analysis of DEGs in the ICGC database and the expression of 40 TFs in ...
Additional file 2: Table S1. List of potential tumor suppressors and oncogenes. Left; Tumor suppress...
Abstract Background Dysregulated expression of long non-coding RNAs (lncRNAs) has been reported in t...
Additional file 2: Figure S2. Volcano plot shown the expression change in HCC when compared with nor...
<p>Despite studying the various molecular mechanisms of hepatocellular carcinoma (HCC), effective dr...
Figure S1. Promoter methylation of four genes. Figure S2 Stage-related methylation of six HCC-specif...
Figure S3. Distribution of TRIM28 expression level in MAGEC2-positive and MAGEC2-negative tissues of...
Additional file 7: Fig. S3. Hypermethylation driven inhibition of metabolic pathways and hypomethyla...
Additional file 3: Fig. S2. Metabolic balance between HCC and adjacent normal tissues. Bar graph sho...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Objective: Various treatments have greatly reduced the mortality of hepatocellular carcinoma (HCC). ...
Figure S1. The association between PPM1F expression and the genetic and methylation alterations in H...
Hepatocellular carcinoma (HCC) accounts for 90% of primary hepatic malignancies and is one of the ma...
Table S2. HCC-associated genes. Contains a set of genes often associated with HCC, including those r...
Additional file 8: Fig. S4. mRNA-GS is associated with less aggressive state in HCC. Dot-plots showi...
Additional file 1: Figure S1. Analysis of DEGs in the ICGC database and the expression of 40 TFs in ...
Additional file 2: Table S1. List of potential tumor suppressors and oncogenes. Left; Tumor suppress...
Abstract Background Dysregulated expression of long non-coding RNAs (lncRNAs) has been reported in t...
Additional file 2: Figure S2. Volcano plot shown the expression change in HCC when compared with nor...
<p>Despite studying the various molecular mechanisms of hepatocellular carcinoma (HCC), effective dr...
Figure S1. Promoter methylation of four genes. Figure S2 Stage-related methylation of six HCC-specif...
Figure S3. Distribution of TRIM28 expression level in MAGEC2-positive and MAGEC2-negative tissues of...
Additional file 7: Fig. S3. Hypermethylation driven inhibition of metabolic pathways and hypomethyla...
Additional file 3: Fig. S2. Metabolic balance between HCC and adjacent normal tissues. Bar graph sho...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Objective: Various treatments have greatly reduced the mortality of hepatocellular carcinoma (HCC). ...
Figure S1. The association between PPM1F expression and the genetic and methylation alterations in H...
Hepatocellular carcinoma (HCC) accounts for 90% of primary hepatic malignancies and is one of the ma...
Table S2. HCC-associated genes. Contains a set of genes often associated with HCC, including those r...